Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug barriers

Women of reproductive potential prescribed efavirenz should be counseled on its potentially teratogenic effects and the importance of birth control. Additionally, nevirapine, nelfinavir, ritonavir, lopinavir/ritonavir, and tipranavir/ritonavir have been shown to decrease the concentrations of estrogens and/or progestins in oral contraceptives, which could lead to failure.2 For patients prescribed these drugs, barrier forms of contraception are preferred to prevent pregnancy. DepoProvera may be... [Pg.1267]

The multidrug transporter P-glycoprotein is expressed in the endothelial lining of the brain and testis but not in other organs and is thought to be a major component of the blood-brain and blood-testis drug barriers. [Pg.634]

PROTEASE INHIBITORS PROGESTOGENS -NORETHISTERONE t adverse effects with amprenavir and atazanavir. Possibly 1 efficacy and risk of contraceptive failure with nelfinavir and ritonavir (with or without lopinavir) Uncertain Advise patients to use additional contraception for the period of intake and for 1 month after stopping coadministration with these drugs. Barrier methods are necessary to prevent transmission of infection from patients with HIV. Watch for early features of toxicity of amprenavir and atazanavir, and adjust the dose accordingly... [Pg.627]

Concerning the distribution of a drug, models have been published for log BB blood/brain partition coefficient) for CNS-active drugs (CNS, central nervous system) crossing the blood-brain barrier (BBB) [38-45] and binding to human serum albumin (HSA) [46]. [Pg.608]

Blood-brain barrier permeation of 7, among other drugs, was predicted from its three-dimensional molecular structure by a computational method (0OJMC2204). The combination of molecular topological methods using 137 quinolones, including 7 provided an excellent tool for the design of new... [Pg.292]

The sedation side effect commonly observed on administration of classical antihistaminic drugs has been attributed in part to the ease with which many of these compounds cross the blood brain barrier. There have been developed recently a series of agoits, for example, terfenadine (198), which cause reduced sedation by virtue of decreased penetration into the CNS. This is achieved by making them more hydrophilic. Synthesis of a related compound, ebastine (197),... [Pg.48]

The outer membrane of gram-negative bacteria is a permeability barrier that allows the passive diffusion of small hydrophilic antibiotics only through aqueous channels, the porins. Drugs larger than 800 Da are... [Pg.772]

Alternate ways to interfere with the orexin system may be via inhibition of dipeptidyl peptidases or proteolysis-resistant peptide analogs as shown for other peptides. This could prolong and boost orexinergic signaling. OX-A but not OX-B can enters the brain by simple diffusion via the blood-brain barrier. Abundance of orexins and their receptors in the olfactory bulb and throughout all parts of the central olfactory system may offer transnasal routes for drug application. [Pg.913]

The symptoms of parkinsonism are caused by a depletion of dopamine in the CNS. Dopamine, when given orally, does not cross the blood-brain barrier and therefore is ineffective The body s blood-brain barrier is a mesh-work of tightly packed cells in die walls of the brain s capillaries that screen out certain substances. This unique meshwork of cells in the CNS prohibits large and potentially harmful molecules from crossing into die brain. This ability to screen out certain substances lias important implications for drug dierapy because some drugs are able to pass through die blood-brain barrier more easily dian odiers. [Pg.265]

Levodopa is a chemical formulation found in plants and animals that is converted into dopamine by nerve cells in the brain. Levodopa does cross die blood-brain barrier, and a small amount is dien converted to dopamine. This allows the drug to have a pharmacologic effect in patients witii Parkinson s disease (Pig. 29-1). Combining levodopa witii another drug (carbidopa) causes more levodopa to reach die brain. When more levodopa is available, the dosage of levodopa may be reduced. Carbidopa has no effect when given alone. Sinemet is a combination of carbidopa and levodopa and is available in several combinations (eg, Sinemet 10/100 has 10 mg of carbidopa and 100 mg of levodopa Sinemet CR is a time-released version of die combined drugs). [Pg.265]

The COMT inhibitors are used as adjuncts to levodopa7 carbidopa in Fhrkinson s disease Tolcapone is a potent COMT inhibitor that easily crosses the blood-brain barrier. However, the drug is associated with liver damage... [Pg.268]


See other pages where Drug barriers is mentioned: [Pg.103]    [Pg.682]    [Pg.759]    [Pg.103]    [Pg.682]    [Pg.759]    [Pg.464]    [Pg.149]    [Pg.68]    [Pg.362]    [Pg.505]    [Pg.490]    [Pg.365]    [Pg.267]    [Pg.163]    [Pg.169]    [Pg.192]    [Pg.195]    [Pg.5]    [Pg.7]    [Pg.116]    [Pg.149]    [Pg.165]    [Pg.242]    [Pg.432]    [Pg.590]    [Pg.676]    [Pg.752]    [Pg.835]    [Pg.907]    [Pg.912]    [Pg.946]    [Pg.948]    [Pg.1158]    [Pg.22]    [Pg.27]    [Pg.53]    [Pg.603]    [Pg.63]    [Pg.236]    [Pg.26]   
See also in sourсe #XX -- [ Pg.533 ]




SEARCH



Blood brain barrier drug efflux transport systems role

Blood brain barrier drug modification

Blood brain barrier restricting drug efflux

Blood brain barrier vector-mediated drug delivery

Blood-brain barrier drug delivery

Blood-brain barrier drug efflux system

Blood-brain barrier nasal drug delivery

Blood-brain barrier, drug distribution

Blood-cerebrospinal fluid barrier drug distribution

Cellular and Biochemical Barriers, Multi-drug Resistance

Central nervous system drugs blood-brain barrier

Colonic epithelium drug absorption barrier

Corneal barriers, ocular drug delivery

Drug development company barriers

Drug distribution tissue barriers

Drugs blood-brain barrier

Gastrointestinal lipophilic drug absorption barriers

Lipophilic drug absorption barriers

Lipophilic drug absorption enterocyte barriers

Ocular drug delivery physiological barriers

Ocular drug delivery precorneal barriers

Ocular drug delivery retinal barriers

Oral drug delivery barriers

Oral drug delivery biological barriers

Oral drug delivery mucus barrier

The Conjunctival Barrier in Ocular Drug Delivery

The Intestinal Mucosa as a Physical and Biochemical Barrier to Drug Absorption

© 2024 chempedia.info